Quantum Biopharma ( (TSE:QNTM) ) just unveiled an announcement.
Quantum BioPharma Ltd. has announced its dual listing on Upstream, a global securities trading app, under the ticker symbol ‘QNTM’. This move aims to provide international investors with streamlined access to Quantum shares, enhancing liquidity and expanding the company’s reach to a broader investor base, while maintaining its listings on Nasdaq, the Canadian Securities Exchange, and Frankfurt exchanges.
More about Quantum Biopharma
Quantum BioPharma Ltd. is a biopharmaceutical company focused on developing innovative assets and biotech solutions aimed at treating neurodegenerative and metabolic disorders, as well as alcohol misuse disorders. The company has a range of drug candidates in various stages of development and operates in a global market.
YTD Price Performance: -17.16%
Average Trading Volume: 137,757
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $6.94M
Find detailed analytics on QNTM stock on TipRanks’ Stock Analysis page.